Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated)
-
* Corresponding author: Andrew F Shorr afshorr@dnamail.com
Critical Care 2008, 12:R45 doi:10.1186/cc6854
Accesses
- Last 30 days: 39 accesses
- Last year: 864 accesses
- All time: 6658 accesses
Cited by
BioMed Central: 3 citations
|
Research
Andrew F Shorr, Jonathan M Janes, Antonio Artigas, Jyrki Tenhunen, Duncan LA Wyncoll, Emmanuelle Mercier, Bruno Francois, Jean-Louis Vincent, Burkhard Vangerow, Darell Heiselman, Amy G Leishman, Yajun E Zhu, Konrad Reinhart, Critical Care 2010, 14:R229 (21 December 2010) |
|
Commentary
Activated protein C in severe acute pancreatitis without sepsis? Not just yet ... Manu Shankar-Hari, Duncan Wyncoll Critical Care 2010, 14:188 (9 August 2010) |
|
Commentary
Protein C as a surrogate end-point for clinical trials of sepsis Kathleen D Liu, Michael A Matthay Critical Care 2008, 12:139 (24 April 2008) |